Table 2 Results of dendritic-cell (DC) immunotherapy
Case | No. of vaccination | Total amount of DCs (× 106) | Radiological findings | Adverse effects | Overall survival (weeks) | Outcome |
|---|---|---|---|---|---|---|
1 | 2(id) | 10(id) | NC | No | 73 | Dead |
2 | 2(id), 2(it) | 17(id), 17(it) | NC | No | 216 | Dead |
3 | 4(id), 4(it) | 42.4(id),52.4(it) | MR | No | 100 | Dead |
4 | 1(id), 1(it) | 12.6(id),12.6(it) | NC | No | 188 | Dead |
5 | 2(id), 2(it) | 64(id), 64(it) | PD | No | 63 | Dead |
6 | 10(id), 7(it) | 137.2(id),106.6(it) | MR | Grade 1 | 308+ | SD |
7 | 3(id) | 46(id) | PD | No | 52 | Dead |
8 | 6(id) | 37.5(id) | NC | No | 60 | Dead |
9 | 4(id) | 28.2(id) | PD | No | 98 | Dead |
10 | 3(id) | 20.6(id) | PD | No | 564+ | PD |
SD=stable disease; PR=partial response; MR=minor response; NC=no change; PD=progressive disease; id=intradermal vaccination; it=intratumoral vaccination. | ||||||
